Results showed mRNA expression of CS in ovarian carcinoma tissues was 1.843 times of ovarian benign tumors (P = 0.0064) (Fig. 1A), the protein level was also upregulated in human ovarian carcinoma compared with the benign tumors (Fig. 1B). Here, CS is linked to benign neoplasm.